| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 347.63B | 346.69B | 312.68B | 282.50B | 263.91B | 283.08B |
| Gross Profit | 46.50B | 44.63B | 43.05B | 42.02B | 38.54B | 38.31B |
| EBITDA | 14.51B | 13.05B | 14.21B | 13.57B | 13.18B | 13.74B |
| Net Income | 7.09B | 6.45B | 9.16B | 7.53B | 6.73B | 7.47B |
Balance Sheet | ||||||
| Total Assets | 257.97B | 269.73B | 245.15B | 233.96B | 236.72B | 220.83B |
| Cash, Cash Equivalents and Short-Term Investments | 32.99B | 35.72B | 26.79B | 36.05B | 67.90B | 73.37B |
| Total Debt | 18.78B | 30.60B | 21.57B | 15.59B | 32.69B | 31.55B |
| Total Liabilities | 121.27B | 131.97B | 111.08B | 106.20B | 115.25B | 105.07B |
| Stockholders Equity | 136.64B | 137.71B | 134.03B | 127.72B | 121.43B | 115.72B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.73B | -13.70B | -13.25B | -1.88B | -7.57B |
| Operating Cash Flow | 0.00 | 5.13B | -10.48B | -6.28B | 2.51B | -4.12B |
| Investing Cash Flow | 0.00 | -1.70B | -2.07B | -5.35B | -6.55B | -7.30B |
| Financing Cash Flow | 0.00 | 5.46B | 3.24B | -19.56B | -1.18B | 12.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥143.38B | 9.06 | ― | 3.22% | 12.23% | 43.29% | |
79 Outperform | ¥93.01B | 15.89 | ― | 3.63% | 35.73% | 62.37% | |
75 Outperform | ¥127.67B | 8.40 | ― | 3.13% | 5.39% | 33.02% | |
68 Neutral | ¥150.44B | 9.00 | ― | 2.89% | 20.38% | 128.85% | |
64 Neutral | ¥115.80B | 13.33 | ― | 2.13% | 7.22% | 21.92% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥61.24B | 19.35 | ― | 1.57% | 11.01% | 231.83% |